The current guidelines recommend screening for<unk>  cardiomyopathy in individuals with 2 or 3 family members with primary<unk>  can be performed using electrocardiograms and echocardiography to measure the size and function of the left ventricle. An underlying genetic mutation in the 40 genes (currently assessed in FCD genetic testing) can be detected in 30 to 40% of FCD patients.
Dilated cardiomyopathy screening
Left ventricular aneurysm screening
Hypertrophic cardiomyopathy screening
Abdominal aortic aneurysm screening
Brugada syndrome screening
Noncompaction cardiomyopathy screening
Bicuspid aortic stenosis screening
Fibromuscular dysplasia screening